JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1994) 140, 1-3       DOI: 10.1677/joe.0.1400001
© 1994 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gilmour, R S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gilmour, R S

The implications of insulin-like growth factor mRNA heterogeneity

R S Gilmour

Our perception of insulin-like growth factor-I (IGF-I) as a growth promoter stems from the original proposal of Salmon & Daughaday (1957) that it mediates the biological actions of pituitary growth hormone (GH). The primary target for GH, it was proposed, is the liver which is stimulated to synthesize IGF-I. The resultant increase in circulating levels of IGF-I promotes cell division and constitutes a major component of the growth response. There is a large body of evidence which relates serum IGF-I concentrations to growth rates; moreover, the liver is the major source of the hormone since it has the highest tissue level of IGF-I mRNA (Murphy et al. 1987) and its synthesis of IGF-I peptide can account, in theory, for the known turnover of IGF-I in the circulation (Schwander et al. 1983).

Subsequently it was shown that IGFs are synthesized to varying degrees in many other tissues. While these observations indicate




This article has been cited by other articles:


Home page
In VivoHome page
A. PHILIPPOU, E. PAPAGEORGIOU, G. BOGDANIS, A. HALAPAS, A. SOURLA, M. MARIDAKI, N. PISSIMISSIS, and M. KOUTSILIERIS
Expression of IGF-1 Isoforms after Exercise-induced Muscle Damage in Humans: Characterization of the MGF E Peptide Actions In Vitro
In Vivo, July 1, 2009; 23(4): 567 - 575.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. A. BLOOR, R. A. KNIGHT, R. K. KEDIA, M. A. SPITERI, and J. T. ALLEN
Differential mRNA Expression of Insulin-like Growth Factor-1 Splice Variants in Patients With Idiopathic Pulmonary Fibrosis and Pulmonary Sarcoidosis
Am. J. Respir. Crit. Care Med., July 15, 2001; 164(2): 265 - 272.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. J. Lewis, T. J. Wester, D. G. Burrin, and M. J. Dauncey
Exogenous growth hormone induces somatotrophic gene expression in neonatal liver and skeletal muscle
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2000; 278(4): R838 - R844.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. T. Allen, C. A. Bloor, R. A. Knight, and M. A. Spiteri
Expression of Insulin-like Growth Factor Binding Proteins in Bronchoalveolar Lavage Fluid of Patients with Pulmonary Sarcoidosis
Am. J. Respir. Cell Mol. Biol., August 1, 1998; 19(2): 250 - 258.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
B. Velasco, L. Cacicedo, J. Escalada, J. Lopez-Fernandez, and F. Sanchez-Franco
Growth Hormone Gene Expression and Secretion in Aging Rats Is Age Dependent and Not Age-Associated Weight Increase Related
Endocrinology, March 1, 1998; 139(3): 1314 - 1320.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. Melian, B. Velasco, R. Barrios, and F. Sanchez-Franco
Basal and Growth Hormone-Induced Hepatic Messenger Ribonucleic Acid Expression of Insulin-Like Growth Factor-I (IGF-I) and IGF-Binding Protein-3 Is Independent of Hyperinsulinemia and Increased Energy Status in the Genetically Obese Zucker Rat
Endocrinology, March 1, 1997; 138(3): 1066 - 1071.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
E. Sviderskaya, W. Wakeling, and D. Bennett
A cloned, immortal line of murine melanoblasts inducible to differentiate to melanocytes
Development, January 5, 1995; 121(5): 1547 - 1557.
[Abstract] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the Society for Endocrinology.